Zeronda Tyler 4

What Happened
Zeronda Tyler, Chief Financial Officer of VYNE Therapeutics (VYNE), had 3,464 shares withheld by the company to satisfy tax withholding related to the vesting of restricted stock units (RSUs). The reported per-share withholding value was $0.65, totaling approximately $2,254. This was a tax-withholding disposition (not an open-market sale or purchase).

Key Details

• Transaction date and price: June 30, 2026 — 3,464 shares at $0.65 per share (total ~$2,254).
• Transaction type/code: F — shares withheld to satisfy tax withholding on vested RSUs.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: F1 indicates the issuer withheld shares to meet tax obligations on vesting.
• Filing timeliness: Form 4 filed July 2, 2026 — appears to be timely (within the standard two-business-day filing window).

Context
Withholding shares for taxes is a routine administrative action when RSUs vest; it is a cashless method the company uses to cover tax liabilities and does not necessarily indicate the insider is selling shares on the market. Retail investors should treat this as a standard tax-related disposition rather than a signal of insider sentiment.